Ultrasound-guided Minimally Invasive Interventional Therapy with a Water Needle Knife for Cervical Spondylotic Radiculopathy: a clinical study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026633

Enrollment

Unknown

Registered

2019-10-16

Start date

2019-10-20

Completion date

Unknown

Last updated

2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical spondylotic radiculopathy

Interventions

Study Group:Ultrasound-guided Minimally Invasive Interventional Therapy with a Water Needle Knife

Control group:Ultrasound-guided Selective Nerve Root Block

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients with clearly diagnosed cervical spondylotic radiculopathy and course of disease less than 26 weeks; 2. patients agd 20-80 years; 3. patients agreed to receive treatment and signed informed consent for clinical trials.

Exclusion criteria

Exclusion criteria: 1. patients with peripheral nerve and blood vessel entrapment of the upper limbs leading to numbness and pain, such as thoracic outlet syndrome, carpal tunnel syndrome, cubital tunnel syndrome, etc.; 2. patients with soft-tissue injuries of the neck, shoulder, back and upper limbs, such as trauma, myofascitis, frozen shoulder, external humeral epicondylitis, etc.; 3. patients with cervical spinal cord diseases, such as syringomyelia, spinal cord infection, spinal cord tumors, etc.; 4. patients with other diseases with similar symptoms, such as cervical tuberculosis, herpes zoster neuralgia, angina pectoris, complex regional pain syndrome, etc.; 5. patients complicated with severe heart, lung, liver and kidney dysfunction, diseases of the hematopoietic system and mental disorders, or pregnant women; 6. patients with drugs or treatment after open cervical surgery and during the trial that might affect the evaluation of efficacy; 7. patients who were unwilling to undergo minimally invasive interventional therapy, could not tolerate pain during the course of treatment or gave up continuous therapy due to severe adverse reactions.

Design outcomes

Primary

Measure	Time frame
Neck Disability Index;	—

Secondary

Measure	Time frame
Visual Analogue Scale/Score;the MOS item short from health survey, SF-36;Clinical efficacy evaluation criteria of Odom;	—

Countries

China

Contacts

Public ContactYe Cao

Second People's Hospital of Zhangjiagang City

caoyezongkehong@126.com+86 13962237065

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026